These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Defective LDL receptors that are common in a large population. Familial hypercholesterolaemia in South Africa. Gevers W; Casciola LA; Fourie AM; Sanan DA; Coetzee GA; van der Westhuyzen DR Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1233-43. PubMed ID: 3322320 [No Abstract] [Full Text] [Related]
23. [Screening and treatment of children and adolescents with hypercholesterolemias and dyslipidemias]. Sobra J Cas Lek Cesk; 1998 Feb; 137(3):67-72. PubMed ID: 9511274 [TBL] [Abstract][Full Text] [Related]
25. Yellowish intertriginous plaques in a young girl: a clue to homozygous familial hypercholesterolaemia. Bhatia R; Chakraborty A; Durgapal P; Walia R; Kaur D Postgrad Med J; 2020 Nov; 96(1141):718. PubMed ID: 31911449 [No Abstract] [Full Text] [Related]
26. Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia. Minhas R; Humphries SE; Qureshi N; Neil HA; Heart; 2009 Apr; 95(7):584-7; discussion 587-91. PubMed ID: 19168470 [No Abstract] [Full Text] [Related]
30. Follow up after a family based genetic screening programme for familial hypercholesterolaemia: is screening alone enough? Van Maarle MC; Stouthard ME; Marang-Van De Mheen PJ; Klazinga NS; Bonsel GJ BMJ; 2002 Jun; 324(7350):1367-8. PubMed ID: 12052805 [No Abstract] [Full Text] [Related]
31. A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiology. Watts GF; van Bockxmeer FM; Bates T; Burnett JR; Juniper A; O'Leary P Heart Lung Circ; 2010 Jul; 19(7):419-22. PubMed ID: 20363671 [TBL] [Abstract][Full Text] [Related]
33. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia. Datta BN; McDowell IF; Rees A Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514 [TBL] [Abstract][Full Text] [Related]
34. Familial hypercholesterolaemia is underdiagnosed after AMI. Dorsch MF; Lawrance RA; Durham NP; Hall AS BMJ; 2001 Jan; 322(7278):111. PubMed ID: 11203728 [No Abstract] [Full Text] [Related]
35. Screening, diagnosis, and treatment of familial hypercholesterolaemia: a call to action. Crea F Eur Heart J; 2022 Sep; 43(34):3185-3188. PubMed ID: 36068020 [No Abstract] [Full Text] [Related]
36. Familial hypercholesterolaemia: a look back, a look ahead. Hamilton-Craig I Med J Aust; 2005 Aug; 183(4):222; author reply 223. PubMed ID: 16097931 [No Abstract] [Full Text] [Related]
37. Monogenic primary hypercholesterolaemia in South Africa. Rubinsztein DC; van der Westhuyzen DR; Coetzee GA S Afr Med J; 1994 Jun; 84(6):339-44. PubMed ID: 7740380 [TBL] [Abstract][Full Text] [Related]
38. The diagnosis and management of familial hypercholesterolaemia. Marais AD; Firth JC Eur Rev Med Pharmacol Sci; 2005; 9(3):141-9. PubMed ID: 16080633 [TBL] [Abstract][Full Text] [Related]
39. Screening for familial hypercholesterolaemia. Funding is difficult to obtain but screening can be international. Tomlinson B; Lan IW; Hamilton-Craig I BMJ; 2001 Apr; 322(7293):1061-2. PubMed ID: 11349660 [No Abstract] [Full Text] [Related]